These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27007691)

  • 1. Long-Term Results of GH Treatment in Silver-Russell Syndrome (SRS): Do They Benefit the Same as Non-SRS Short-SGA?
    Smeets CC; Zandwijken GR; Renes JS; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2105-12. PubMed ID: 27007691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetic Landscape of Children Born Small for Gestational Age with Persistent Short Stature.
    Toni L; Plachy L; Dusatkova P; Amaratunga SA; Elblova L; Sumnik Z; Kolouskova S; Snajderova M; Obermannova B; Pruhova S; Lebl J
    Horm Res Paediatr; 2024; 97(1):40-52. PubMed ID: 37019085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Hormone Dose Modulation and Final Height in Short Children Born Small for Gestational Age: French Real-Life Data.
    Coutant R; Leheup B; Nicolino M; Salles JP
    Horm Res Paediatr; 2023; 96(5):495-508. PubMed ID: 37040726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Long term response to growth hormone in a child with Silver-Russell syndrome-like phenotype due to a novel paternally inherited IGF2 variant.
    Ventresca S; Lepri FR; Criscuolo S; Bottaro G; Novelli A; Loche S; Cappa M
    Front Endocrinol (Lausanne); 2024; 15():1364234. PubMed ID: 38596219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of and growth hormone treatment effects on short stature with type 1 insulin-like growth factor receptor (IGF1R) gene alteration.
    Kawashima-Sonoyama Y; Wada K; Yamamoto K; Fujimoto M; Namba N; Taketani T
    Endocr J; 2024 Jul; 71(7):687-694. PubMed ID: 38710621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone Therapy.
    Wit JM; Deeb A; Bin-Abbas B; Al Mutair A; Koledova E; Savage MO
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):329-340. PubMed ID: 31284701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging options in growth hormone therapy: an update.
    Kemp SF; Frindik JP
    Drug Des Devel Ther; 2011; 5():411-9. PubMed ID: 21966214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal features of children with Silver-Russell syndrome due to 11p15 loss of methylation.
    Darneau D; Giabicani E; Netchine I; Pham A
    Front Pediatr; 2024; 12():1367433. PubMed ID: 38638586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and medical management of achondroplasia in Japanese children: A retrospective medical record review of clinical data.
    Saitou H; Kitaoka T; Kubota T; Kanno J; Mochizuki H; Michigami T; Hasegawa K; Fujiwara I; Hamajima T; Harada D; Seki Y; Nagasaki K; Dateki S; Namba N; Tokuoka H; Pimenta JM; Cohen S; Ozono K
    Am J Med Genet A; 2024 Aug; 194(8):e63612. PubMed ID: 38554024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome.
    Maharaj AV; Cottrell E; Thanasupawat T; Joustra SD; Triggs-Raine B; Fujimoto M; Kant SG; van der Kaay D; Clement-de Boers A; Brooks AS; Aguirre GA; Martín Del Estal I; Castilla de Cortázar Larrea MI; Massoud A; van Duyvenvoorde HA; De Bruin C; Hwa V; Klonisch T; Hombach-Klonisch S; Storr HL
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38516887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition and metabolism in adults with molecularly-confirmed Silver-Russell syndrome.
    Lokulo-Sodipe O; Inskip HM; Byrne CD; Child J; Wakeling EL; Mackay DJG; Temple IK; Davies JH
    J Clin Endocrinol Metab; 2024 Feb; ():. PubMed ID: 38330234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthodontic management of patient with Silver-Russell Syndrome (SRS). A case report.
    Paglia M; Braiotta F; Quinzi V
    Eur J Paediatr Dent; 2024 Mar; 25(1):69-71. PubMed ID: 38357754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of Silver-Russell syndrome: first international consensus statement.
    Wakeling EL; Brioude F; Lokulo-Sodipe O; O'Connell SM; Salem J; Bliek J; Canton AP; Chrzanowska KH; Davies JH; Dias RP; Dubern B; Elbracht M; Giabicani E; Grimberg A; Grønskov K; Hokken-Koelega AC; Jorge AA; Kagami M; Linglart A; Maghnie M; Mohnike K; Monk D; Moore GE; Murray PG; Ogata T; Petit IO; Russo S; Said E; Toumba M; Tümer Z; Binder G; Eggermann T; Harbison MD; Temple IK; Mackay DJ; Netchine I
    Nat Rev Endocrinol; 2017 Feb; 13(2):105-124. PubMed ID: 27585961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Health and Long-Term Safety of Growth Hormone Treatment in Silver-Russell Syndrome.
    Smeets CC; Renes JS; van der Steen M; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2017 Mar; 102(3):983-991. PubMed ID: 28001454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 14q32.2 Imprinted Region Disruption as an Alternative Molecular Diagnosis of Silver-Russell Syndrome.
    Geoffron S; Abi Habib W; Chantot-Bastaraud S; Dubern B; Steunou V; Azzi S; Afenjar A; Busa T; Pinheiro Canton A; Chalouhi C; Dufourg MN; Esteva B; Fradin M; Geneviève D; Heide S; Isidor B; Linglart A; Morice Picard F; Naud-Saudreau C; Oliver Petit I; Philip N; Pienkowski C; Rio M; Rossignol S; Tauber M; Thevenon J; Vu-Hong TA; Harbison MD; Salem J; Brioude F; Netchine I; Giabicani E
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2436-2446. PubMed ID: 29659920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction.
    Abi Habib W; Brioude F; Edouard T; Bennett JT; Lienhardt-Roussie A; Tixier F; Salem J; Yuen T; Azzi S; Le Bouc Y; Harbison MD; Netchine I
    Genet Med; 2018 Feb; 20(2):250-258. PubMed ID: 28796236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype of genetically confirmed Silver-Russell syndrome beyond childhood.
    Lokulo-Sodipe O; Ballard L; Child J; Inskip HM; Byrne CD; Ishida M; Moore GE; Wakeling EL; Fenwick A; Mackay DJG; Davies JH; Temple IK
    J Med Genet; 2020 Oct; 57(10):683-691. PubMed ID: 32054688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients.
    Wollmann HA; Kirchner T; Enders H; Preece MA; Ranke MB
    Eur J Pediatr; 1995 Dec; 154(12):958-68. PubMed ID: 8801103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.